Concepedia

Clara J. Polizzi

CJ

4

Publications

269

Citations

4

H-Index

2010

Active since

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

Clara J. Polizzi is an author at Amplyx Pharmaceuticals (United States) specializing in health sciences, diabetes, and gastrointestinal pharmacology.

Top concepts

Publications per year

2010–2014

4

Publications

4

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

Que Liu, Christen M. Anderson, Anatoly Broyde et al. · Cardiovascular Diabetology · 2010 · 122 citations · Full text

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Krystyna Tatarkiewicz, Pam Smith, Emmanuel J. Sablan et al. · American Journal of Physiology-Endocrinology and Metabolism · 2010 · 91 citations · Full text

, , +17

Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor

Krystyna Tatarkiewicz, Emmanuel J. Sablan, Clara J. Polizzi et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2014 · 32 citations

, , +18

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice

Krystyna Tatarkiewicz, Clara J. Polizzi, Christiane Villescaz et al. · Diabetes Obesity and Metabolism · 2013 · 24 citations · Full text

Rows per page

1–4 of 4